Protagonist Therapeutics, Inc. Skyrocketed
Tue, Mar 07, 2023 at 07:10 PM
Protagonist Therapeutics, Inc. (PTGX:NASDAQ) shot up at $23.09, representing a gain of 51.9%. On Tue, Mar 07, 2023, PTGX:NASDAQ touched a New 2-Week High of $23.09. The stock got featured on our News Catalysts scanner on Tue, Mar 07, 2023 at 09:23 AM in the 'BIOTECH' category. From Tue, Feb 21, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.
Top 10 Gainers:
- Virax Biolabs Group Limited (VRAX:NASDAQ), 83.31%
- WW International, Inc. (WW:NASDAQ), 79.07%
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 51.91%
- ThredUp Inc. (TDUP:NASDAQ), 51.23%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 43.33%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 42.45%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Siyata Mobile Inc. (SYTA:NASDAQ), 32.65%
- Etao International Co. Ltd. (ETAO:NASDAQ), 30.74%
- Peak Bio Inc Com (PKBO:NASDAQ), 30.45%